Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023
08:05am, Tuesday, 17'th Oct 2023
PLYMOUTH MEETING, Pa. , Oct. 17, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
Harmony Stock Tanks On Study Miss For Narcolepsy Drug: Problems May Be Escalating
04:01pm, Friday, 13'th Oct 2023
Harmony Biosciences' only product, WAKIX - pitolisant - has generated over $1 billion in net revenue since its launch. The company's Q2 2023 earnings showed a 39.6% growth in net product revenues comp
Why Shares of Harmony Bioscience Are Falling on Friday
12:52pm, Friday, 13'th Oct 2023
Harmony has already gotten approval for the drug to treat adults with excessive daytime sleepiness who have narcolepsy. Harmony's second-quarter revenue was up 25%, year over year.
Harmony Biosciences stock drops on disappointing study results
11:29am, Friday, 13'th Oct 2023
Harmony Biosciences Holdings Inc shares sank 38% to $18.66 in late-morning trading on Friday after the pharmaceutical company reported topline results from the INTUNE study of pitolisant, which missed
2 Magnificent Growth Stocks to Buy Right Now
09:25am, Wednesday, 04'th Oct 2023
Growth stocks are an important element of a well-balanced portfolio. Ginkgo Bioworks and Harmony Biosciences are two risky growth plays that could deliver stellar returns over the long term.
Harmony Biosciences: A Balancing Act As Investors Lose Some Sleep
02:16am, Sunday, 24'th Sep 2023
Harmony Biosciences has experienced strong and profitable growth following the approval and commercialization of WAKIX. The company's success has allowed for funding of other programs and acquisitions
HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE
08:05am, Wednesday, 13'th Sep 2023
PLYMOUTH MEETING, Pa. , Sept. 13, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
Harmony Biosciences to buy Zynerba Pharmaceuticals for up to $200 million
09:18am, Monday, 14'th Aug 2023
Shares of Zynerba Pharmaceuticals Inc. ZYNE, +0.89% jumped 300% premarket on Monday after Harmony Biosciences Holdings Inc. HRMY, -0.47% said it would acquire the cannabinoid therapy company in a deal
7 ‘Strong Buy' Value Stocks You Should Be Loading Up On Now
02:44pm, Thursday, 03'rd Aug 2023
Inherently, investors gravitate toward strong buy value stocks, in much the same way that audience members of a horror film might grip their armrests. As humans, we're basically hardwired – especial
Harmony Biosciences Holdings, Inc. (HRMY) Lags Q2 Earnings and Revenue Estimates
10:25am, Tuesday, 01'st Aug 2023
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.57 per share a y
Harmony Biosciences: Rare Low-Volume Accumulation With Short Squeeze Potential
12:43pm, Thursday, 27'th Jul 2023
Harmony Biosciences is a high-margin, high-growth pharmaceutical business, attracting the attention of short sellers. The company's short position is significant. 38% of float has been borrowed then p
HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON AUGUST 1, 2023
08:05am, Tuesday, 18'th Jul 2023
PLYMOUTH MEETING, Pa. , July 18, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
7 Best High-Growth Stocks to Buy if You're a Young Investor
07:00am, Thursday, 29'th Jun 2023
Generally speaking, financial advisors will often direct you to reliable enterprises though, for certain folks, high-growth stocks may make more sense. That's particularly true if you're part of the y
3 Biotech Stocks to Buy With Explosive Upside Potential
09:30am, Thursday, 22'nd Jun 2023
The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case.
HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 44th ANNUAL GLOBAL HEALTHCARE CONFERENCE
08:05am, Tuesday, 30'th May 2023
PLYMOUTH MEETING, Pa. , May 30, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializin
